Novocure Ltd. (NVCR) Social Stream



Novocure Ltd. (NVCR): $58.45

1.38 (+2.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NOVOCURE LTD (NVCR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NOVOCURE LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 7 $200 $85 $151.5 $57.07 165.46%
2022-01-03 8 $200 $82 $141.571 $57.07 148.07%
2022-01-06 8 $200 $82 $134.428 $57.07 135.55%
2022-01-11 8 $200 $45 $112.285 $57.07 96.75%
2022-01-20 8 $200 $45 $112.285 $57.07 96.75%
2022-02-02 8 $200 $45 $110.5 $57.07 93.62%
2022-02-08 9 $200 $45 $120.444 $57.07 111.05%
2022-02-25 9 $200 $45 $114.777 $57.07 101.12%
2022-05-08 9 $200 $45 $114.333 $57.07 100.34%
2022-05-13 9 $200 $45 $111.555 $57.07 95.47%
2022-06-06 10 $200 $45 $111.9 $57.07 96.07%
2022-07-11 9 $200 $45 $113.444 $57.07 98.78%
2022-07-29 9 $200 $45 $110.111 $57.07 92.94%
2022-08-02 7 $200 $45 $98.875 $57.07 73.25%
2022-10-24 7 $200 $45 $96.375 $57.07 68.87%
2022-10-28 7 $200 $45 $94.125 $57.07 64.93%
2022-11-29 8 $200 $43 $96.25 $57.07 68.65%
2022-12-06 8 $200 $43 $96.125 $57.07 68.43%
2022-12-22 8 $200 $43 $96.5 $57.07 69.09%
2023-01-06 8 $200 $65 $109.285 $57.07 91.49%
2023-01-12 8 $200 $65 $111.142 $57.07 94.75%
2023-01-17 8 $200 $65 $112.571 $57.07 97.25%
2023-02-23 7 $130 $65 $97.166 $57.07 70.26%

The Trend in the Analyst Price Target


Over the past 16 months, NVCR's average price target has gone down $54.33.

NVCR reports an average of 34.08% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-29 9 200 45 114.333 76.58 49.3%
2022-07-29 9 200 45 98.875 67.99 45.43%
2022-07-29 9 200 45 110.111 67.99 61.95%
2022-10-28 8 200 43 94.375 70.06 34.71%
2023-01-17 7 135 65 98.000 92.26 6.22%

NVCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 2 0 3 2 2 7

The Trend in the Broker Recommendations


Over the past 123 days, NVCR's average broker recommendation rating worsened by 0.29.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, NOVOCURE LTD's variance in analysts' estimates is lower than -2643.87% of them.
  • NVCR has a higher number of analysts covering the stock than 550.68% of stocks in the large market cap category.
  • NOVOCURE LTD's upside potential (average analyst target price relative to current price) is greater than 2433.37% of stocks in the large market cap category.
  • In terms of how NOVOCURE LTD fares relative to Healthcare stocks, note that its average analyst price target is higher than 2391.62% of that group.

In the Medical Equipment industry, PODD, DXCM, and RMD are the three stocks most similar to NOVOCURE LTD regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding NVCR using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.0253 seconds.